One-Year Transcutaneous Tibial Nerve Stimulation Treatment Persistence in Lower Urinary Tract Dysfunction: Clinical and Urodynamic Associated Factors in a Prospective Observational Study.

Fifty-six patients initiated Transcutaneous Tibial Nerve Stimulation, including 32 (57%) with neurological lower urinary tract dysfunction.

At 1 year, 21/56 patients (38%) remained persistent, including 21/34 (62%) among the device purchasers.

Lower symptom burden and greater perceived improvement at 2-4 months were associated with both device acquisition and long-term persistence, particularly through lower Patient Global Impression of Severity, Patient Global Impression of Improvement, USP-OAB, and QUALIVEEN-Short Form scores.